Free Trial

Enliven Therapeutics (ELVN) Institutional Ownership

Enliven Therapeutics logo
$43.08 -0.48 (-1.10%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$43.20 +0.12 (+0.28%)
As of 04:35 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Enliven Therapeutics (NASDAQ:ELVN)

Current
Institutional Ownership
Percentage
95.08%
Number of
Institutional Buyers
(last 12 months)
73
Total
Institutional Inflows
(last 12 months)
$280.27M
Number of
Institutional Sellers
(last 12 months)
37
Total
Institutional Outflows
(last 12 months)
$93.81M
Get ELVN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Enliven Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ELVN Institutional Buying and Selling by Quarter

Enliven Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/15/2026Affinity Asset Advisors LLC586,904$23.01M1.2%N/A0.964%
5/15/2026Entropy Technologies LP6,101$239K0.0%N/A0.010%
5/15/2026Spruce Street Capital LP329,006$12.90M3.1%-26.2%0.540%
5/14/2026Siren L.L.C.746,226$29.25M0.8%N/A1.225%
5/14/2026 Walleye Capital LLC37,827$1.48M0.0%N/A0.062%
5/7/2026 Dimensional Fund Advisors LP681,715$26.71M0.0%+70.9%1.119%
5/7/2026 KBC Group NV958$38K0.0%N/A0.002%
5/6/2026 Jennison Associates LLC309,180$12.12M0.0%N/A0.508%
5/5/2026 Bank of New York Mellon Corp120,057$4.71M0.0%+8.6%0.197%
5/1/2026 Candriam S.C.A.594,079$23.29M0.1%+31.1%0.975%
4/24/2026 Capricorn Fund Managers Ltd369,400$14.48M2.3%N/A0.607%
4/22/2026 Pictet Asset Management Holding SA929,544$36.44M0.0%-28.7%1.526%
2/26/2026Seven Fleet Capital Management LP11,688$180K0.1%N/A0.020%
2/19/2026 Invesco Ltd.24,720$381K0.0%+7.0%0.042%
2/18/2026XTX Topco Ltd60,702$935K0.0%+472.6%0.102%
2/18/2026Vestal Point Capital LP3,830,000$58.98M2.0%+230.2%6.454%
2/18/2026Virtus Investment Advisers LLC15,778$243K0.1%+172.6%0.027%
2/18/2026Wellington Management Group LLP129,876$2M0.0%+19.6%0.219%
2/18/2026Susquehanna Portfolio Strategies LLC48,741$751K0.0%+53.6%0.082%
2/18/2026Tudor Investment Corp ET AL29,673$457K0.0%+82.0%0.050%
2/18/2026Sphera Funds Management LTD.226,765$3.49M0.7%+36.0%0.382%
2/18/2026Millennium Management LLC296,947$4.57M0.0%-22.1%0.500%
2/18/2026Janus Henderson Group PLC1,671,724$25.75M0.0%-6.8%2.817%
2/18/2026Baker BROS. Advisors LP271,406$4.18M0.0%+136.3%0.457%
2/17/2026ADAR1 Capital Management LLC30,000$462K0.0%N/A0.051%
2/17/2026Jump Financial LLC45,354$698K0.0%N/A0.076%
2/17/2026Price T Rowe Associates Inc. MD23,800$367K0.0%-89.7%0.040%
2/17/2026Rock Springs Capital Management LP798,405$12.30M0.6%+16.4%1.345%
2/17/2026California State Teachers Retirement System32,206$496K0.0%+58.4%0.054%
2/17/2026 Russell Investments Group Ltd.3,121$48K0.0%-14.3%0.005%
2/17/2026State of Wisconsin Investment Board20,398$314K0.0%-57.2%0.034%
2/17/2026ExodusPoint Capital Management LP60,415$930K0.0%+25.5%0.102%
2/17/2026Polar Capital Holdings Plc3,513,680$54.11M0.2%+13.5%5.920%
2/16/2026Squarepoint Ops LLC20,763$320K0.0%-42.1%0.035%
2/16/2026Spruce Street Capital LP446,084$6.87M2.3%N/A0.752%
2/16/2026Barclays PLC69,875$1.08M0.0%-1.2%0.118%
2/13/2026Marshall Wace LLP371,906$5.73M0.0%+9.2%0.627%
2/13/2026The Manufacturers Life Insurance Company 19,336$298K0.0%-56.1%0.033%
2/13/2026Exome Asset Management LLC222,308$3.42M1.6%N/A0.375%
2/13/2026Charles Schwab Investment Management Inc.355,192$5.47M0.0%-2.2%0.598%
SpaceX eyes a 1.75 trillion valuation - here's what to know (Ad)

Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500.tc pixel

See how to get positioned in SpaceX before the announcement goes public
2/13/2026State Street Corp1,052,862$16.21M0.0%+9.1%1.774%
2/13/2026 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC55,210$850K0.0%+6.8%0.093%
2/13/2026 Wells Fargo & Company MN43,056$663K0.0%+66.7%0.073%
2/12/2026 Dimensional Fund Advisors LP398,893$6.14M0.0%+148.6%0.672%
2/12/2026Patient Square Capital LP308,141$4.75M1.0%+22.8%0.519%
2/12/2026 New York State Common Retirement Fund9,097$140K0.0%-39.7%0.015%
2/12/2026 Swiss National Bank64,273$990K0.0%+1.7%0.108%
2/12/2026 Nuveen LLC105,448$1.62M0.0%-2.6%0.178%
2/11/2026 Deutsche Bank AG31,420$484K0.0%+24.7%0.053%
2/11/2026 Fox Run Management L.L.C.12,432$191K0.0%N/A0.021%
2/11/2026 Franklin Resources Inc.20,167$311K0.0%-95.3%0.034%
2/11/2026 Capital Research Global Investors1,304,346$20.09M0.0%-0.8%2.198%
2/11/2026 Los Angeles Capital Management LLC5,409$83K0.0%N/A0.009%
2/10/2026Goldman Sachs Group Inc.237,204$3.65M0.0%-9.6%0.400%
2/10/2026 AXQ Capital LP14,244$219K0.0%N/A0.024%
2/10/2026 Intech Investment Management LLC16,729$258K0.0%+15.6%0.028%
2/9/2026Geode Capital Management LLC1,048,722$16.15M0.0%-3.3%1.767%
1/29/2026 Pictet Asset Management Holding SA1,303,235$20.07M0.0%-6.8%2.196%
1/29/2026 China Universal Asset Management Co. Ltd.9,671$149K0.0%-6.9%0.016%
1/27/2026Zurcher Kantonalbank Zurich Cantonalbank6,163$95K0.0%N/A0.010%
1/26/2026 Mirae Asset Global Investments Co. Ltd.2,884$44K0.0%+25.9%0.005%
1/9/2026 SG Americas Securities LLC14,035$216K0.0%-36.9%0.024%
1/1/2026 JPMorgan Chase & Co.24,818$508K0.0%+30.2%0.042%
1/1/2026Tudor Investment Corp ET AL16,303$334K0.0%N/A0.027%
12/9/2025Tudor Investment Corp ET AL16,303$334K0.0%N/A0.027%
11/17/2025Woodline Partners LP300,499$6.15M0.0%-72.7%0.506%
11/17/2025Vestal Point Capital LP1,160,000$23.75M1.1%+364.0%1.955%
11/17/2025Polar Capital Holdings Plc3,095,007$63.36M0.3%+1.5%5.215%
11/17/2025Millennium Management LLC381,405$7.81M0.0%+19.8%0.643%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.19,529$400K0.0%+10.6%0.033%
11/17/2025HighVista Strategies LLC259,135$5.30M1.3%+83.1%0.437%
11/17/2025Citadel Advisors LLC1,160,503$23.76M0.0%-21.1%1.955%
11/17/2025Bank of America Corp DE23,543$482K0.0%-3.9%0.040%
11/17/2025Ameriprise Financial Inc.123,336$2.53M0.0%+108.2%0.208%
11/14/2025Man Group plc13,371$274K0.0%N/A0.023%
11/14/2025Duquesne Family Office LLC947,405$19.39M0.5%+104.6%1.599%
11/14/2025 UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC51,683$1.06M0.0%-37.8%0.087%
11/14/2025Squarepoint Ops LLC35,845$734K0.0%N/A0.061%
11/13/2025Marshall Wace LLP340,482$6.97M0.0%+2.1%0.575%
11/13/2025 Landscape Capital Management L.L.C.10,301$211K0.0%N/A0.017%
11/13/2025 UBS Group AG79,508$1.63M0.0%-42.5%0.134%
11/13/2025 BNP Paribas Financial Markets9,144$187K0.0%+145.7%0.015%
11/13/2025 Legal & General Group Plc33,765$691K0.0%+4.8%0.057%
11/13/2025 WINTON GROUP Ltd16,458$337K0.0%N/A0.028%
11/13/2025 Russell Investments Group Ltd.3,642$75K0.0%-87.7%0.006%
11/12/2025Barclays PLC70,689$1.45M0.0%-2.9%0.119%
11/12/2025 Dimensional Fund Advisors LP160,459$3.28M0.0%+242.5%0.271%
11/12/2025 Quantbot Technologies LP2,146$44K0.0%-52.1%0.004%
11/10/2025 TD Asset Management Inc27,518$563K0.0%-58.9%0.046%
11/10/2025Patient Square Capital LP250,838$5.14M1.4%+2.0%0.423%
SpaceX eyes a 1.75 trillion valuation - here's what to know (Ad)

Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500.tc pixel

See how to get positioned in SpaceX before the announcement goes public
11/7/2025NEOS Investment Management LLC40,314$825K0.0%+23.7%0.068%
11/7/2025Vanguard Group Inc.2,553,014$52.26M0.0%+5.9%4.310%
11/7/2025 JPMorgan Chase & Co.24,818$508K0.0%+30.2%0.042%
11/6/2025 Rhumbline Advisers60,160$1.23M0.0%+19.6%0.102%
11/6/2025 Candriam S.C.A.609,352$12.47M0.1%+46.3%1.029%
11/3/2025 AlphaQuest LLC4,701$96K0.0%N/A0.008%
11/3/2025 New York State Common Retirement Fund15,097$309K0.0%+54.1%0.025%
11/3/2025 Federated Hermes Inc.10,811$221K0.0%-32.8%0.018%
10/23/2025 SG Americas Securities LLC22,242$455K0.0%-38.9%0.038%
8/15/2025Tower Research Capital LLC TRC 5,286$106K0.0%+194.3%0.009%


ELVN Institutional Ownership - Frequently Asked Questions

During the previous two years, 119 institutional investors and hedge funds held shares of Enliven Therapeutics. The most heavily invested institutionals were FMR LLC ($146.16M), Commodore Capital LP ($94.14M), Vestal Point Capital LP ($58.98M), Polar Capital Holdings Plc ($54.11M), Vanguard Group Inc. ($52.26M), Pictet Asset Management Holding SA ($36.44M), and Siren L.L.C. ($29.25M).Learn more on Enliven Therapeutics' institutional investors.

95.08% of Enliven Therapeutics' stock is owned by institutional investors. Learn more on ELVN's institutional investor holdings.

Of the 100 institutional investors that purchased Enliven Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vestal Point Capital LP ($3.58M), Polar Capital Holdings Plc ($2.20M), Duquesne Family Office LLC ($947.41K), Janus Henderson Group PLC ($908.57K), FMR LLC ($801.30K), Candriam S.C.A. ($750.41K), and Siren L.L.C. ($746.23K).

Institutional investors have bought a total of 12,097,236 shares in the last 24 months. This purchase volume represents approximately $257.49M in transactions.

Of the 36 institutional investors that sold Enliven Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: 5AM Venture Management LLC ($857.29K), Woodline Partners LP ($800.92K), Adage Capital Partners GP L.L.C. ($554K), Pictet Asset Management Holding SA ($468.54K), Franklin Resources Inc. ($410.07K), Citadel Advisors LLC ($309.92K), and Price T Rowe Associates Inc. MD ($207.50K).

Institutional investors have sold a total of 4,326,351 shares in the last 24 months. This volume of shares sold represents approximately $89.22M in transactions.



This page (NASDAQ:ELVN) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners